TerrAscend Stock Forecast, Price & News

TerrAscend (OTCMKTS:TRSSF) Frequently Asked Questions

Is TerrAscend a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TerrAscend in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TerrAscend stock.
View analyst ratings for TerrAscend or view top-rated stocks.

How has TerrAscend's stock price been impacted by COVID-19 (Coronavirus)?

TerrAscend's stock was trading at $1.8277 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TRSSF shares have increased by 173.6% and is now trading at $5.00.
View which stocks have been most impacted by COVID-19.

How were TerrAscend's earnings last quarter?

TerrAscend Corp. (OTCMKTS:TRSSF) issued its quarterly earnings results on Tuesday, November, 16th. The company reported $0.28 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.01) by $0.29.
View TerrAscend's earnings history.

What price target have analysts set for TRSSF?

7 brokers have issued 12-month target prices for TerrAscend's shares. Their forecasts range from $7.65 to $21.00. On average, they expect TerrAscend's stock price to reach $15.02 in the next year. This suggests a possible upside of 200.4% from the stock's current price.
View analysts' price targets for TerrAscend or view top-rated stocks among Wall Street analysts.

Who are TerrAscend's key executives?

TerrAscend's management team includes the following people:

• Ziad Ghanem, President & Chief Operating Officer
• Keith Stauffer, Chief Financial Officer
• Daniel Foley, Treasurer & Senior Vice President
• Ari Unterman, Vice President-Business Development
• Halligan Joanna, Vice President-Human Resources

Who are some of TerrAscend's key competitors?

Some companies that are related to TerrAscend include Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE), CannPal Animal Therapeutics (CP1), Cansortium (CNTMF), Chalice Brands (GLDFF) and Charlotte's Web (CWBHF).
View all of TRSSF's competitors.

What is TerrAscend's stock symbol?

TerrAscend trades on the OTCMKTS under the ticker symbol "TRSSF."

How do I buy shares of TerrAscend?

Shares of TRSSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TerrAscend's stock price today?

One share of TRSSF stock can currently be purchased for approximately $5.00.

What is TerrAscend's official website?

The official website for TerrAscend is www.terrascend.com.

Where are TerrAscend's headquarters?

TerrAscend is headquartered at PO Box 43125, Mississauga, ON L5B.

How can I contact TerrAscend?

TerrAscend's mailing address is PO Box 43125, Mississauga, ON L5B. The company can be reached via phone at (855) 837-7295.